Cannabis Health Symposium 2026 · Frankfurt 4 Nov · London 26 Nov

Your patients are already asking. Be the clinician with answers.

One day of evidence-led education on cannabis-based medicines for prescribers, pharmacists, nurses and allied health professionals — the science, the systems and the practical realities of prescribing.

I am a…

What’s on this page — and where to start

  1. Why attendSix reasons clinicians make the day, from evidence to peers.Go there
  2. Knowledge checkEight questions, three minutes, every answer sourced.Go there
  3. ProgrammeThe sessions built for prescribers, pharmacists and nurses.Go there
  4. StudentsFree places for medical students at both symposia.Go there
  5. TicketsFrankfurt 4 November · London 26 November.Go there
  6. FAQCPD, language, concessions and the MCCS membership.Go there
  1. Knowledge checkPharmacology, interactions and prescribing law — test where you stand.Go there
  2. ProgrammeNHS pathways, CQC compliance, cannabinoids versus opioids, RWE versus RCTs.Go there
  3. Why attendThe evidence, the debates and the peers, in one day.Go there
  4. TicketsTwo cities; 12 months’ MCCS membership included.Go there
  5. FAQCPD status, language and concessions.Go there
  6. StudentsBring your students — free places.Go there
  1. ProgrammeThe pharmacist’s changing role in Germany, product quality and standards.Go there
  2. Knowledge checkCYP interactions, licensed products and who can prescribe.Go there
  3. Why attendHear both sides of the quality and supply debates.Go there
  4. TicketsFrankfurt for the pharmacy session; London for the NHS pathway.Go there
  5. FAQCPD status, language and concessions.Go there
  6. StudentsFree places for medical students.Go there
  1. Why attendPatients arrive informed — the day gives you the evidence to answer them.Go there
  2. Knowledge checkReceptors, interactions, access — three minutes with sources.Go there
  3. ProgrammeMental-health risk and benefit, patient safety, NHS pathways.Go there
  4. TicketsMCCS membership covers nurses, pharmacists and AHPs.Go there
  5. FAQCPD status, language and concessions.Go there
  6. StudentsFree places for medical students.Go there
  1. StudentsFree places at both symposia — apply with your university details.Go there
  2. Knowledge checkSee how much of cannabinoid medicine your curriculum covered.Go there
  3. ProgrammeThe sessions the prescribers are coming for.Go there
  4. Why attendWhy the people shaping the field are in this room.Go there
  5. FAQHow the free places work.Go there
  6. TicketsIf you’d rather book a full ticket.Go there
  1. ProgrammeRWE versus RCTs, pain evidence, harmonised standards, evidence or ideology.Go there
  2. Knowledge checkMechanisms and guidance — see which sources you’d cite.Go there
  3. Why attendThe clinicians generating the data are in the same room.Go there
  4. TicketsTwo cities, one programme philosophy.Go there
  5. FAQLanguage, CPD and concessions.Go there
  6. StudentsFree places for medical students.Go there

Knowledge check · Question 1 of 8

THC’s intoxicating effects come mainly from activating which receptor?

140,000+

people prescribed medical cannabis in the UK during 2026

Prohibition Partners

40+

private clinics now prescribing in the UK

Cannabis Health

41%

of 2025 symposium attendees were decision-makers

138 attendees, 2025

12 months

free MCCS membership with every ticket

worth up to £120

Why clinicians come

Most of cannabinoid medicine was never in the curriculum. The symposium is where the evidence, the pathways and the people who produce them are in one room for a day.

Why clinicians attend · 92 seconds — the evidence, the programme and the people, narrated.

Evidence, not ideology

Chaired debates on what the data actually supports — RCTs versus real-world evidence in London, “Evidence or Ideology?” in Frankfurt — with the researchers who produce it.

Prescribing in practice

NHS pathways and CQC compliance in London; the pharmacist’s changing role, telemedicine and product quality in Frankfurt. Sessions built around the questions you get in clinic.

Hear both sides

Sessions are chaired debates, not sales pitches: cannabinoids versus opioids, telemedicine’s risks and rewards, standards versus rules.

Your peers in one room

Prescribers, pharmacists, regulators, researchers and clinic founders — the people you would otherwise spend a year trying to reach, across one day of sessions and breaks.

CPD

London: CPD accreditation pending. Frankfurt is not CPD-accredited — come for the programme.

The patients are already here

In the UK only doctors on the GMC Specialist Register can initiate a cannabis-based medicine, usually after two conventional treatments have failed — and more than 140,000 people were prescribed one in 2026. Patients arrive informed; the day gives you the evidence to answer them.

Knowledge check

How current is your cannabinoid knowledge?

Eight questions, about three minutes. Instant answers with sources — then a personalised view of the sessions that fill your gaps.

Built for clinicians: the sessions to plan your day around

A selection from each programme. Times and speakers update as the line-ups are confirmed.

Frankfurt · 4 November 2026

  1. 10:20Telemedicine Debate: Revolution or Risk for Medical CannabisFor youPanel debate · Dr. Christiane Neubaur, Tobias Bosse, Dr. Julian Wichmann
  2. 11:00Pharmaceutical Quality: Does Europe Need a Common Framework for Medical Cannabis?For youPanel discussion · Ana Serrato, Tjalling Erkelens
  3. 13:30The Changing Role and Responsibilities of Pharmacists in GermanyFor youPresentation & discussion · Antonia Menzel
  4. 14:00Cannabinoids vs Opioids: A New Effective Class of Treatment for Chronic Pain?For youPresentation · Michael Ueberall
  5. 14:20Evidence or Ideology? Making Cannabis Policy Without DataFor youPanel discussion · Professor Bernd Werse, Sita Schubert, Dr. Artur Schrörs
Full Frankfurt programme

London · 26 November 2026

  1. 10:00Cannabis-based medicines and NHS pathwaysFor youPresentation
  2. 10:20Building a safe, effective and compliant medical cannabis serviceFor youPanel discussion
  3. 14:00Managing risk and maximising benefit in mental health careFor youPanel discussion · Alex Fraser
  4. 15:00RCT vs RWE: is it time to look beyond the placebo-controlled trial?For youDebate · Professor David Nutt
  5. 15:50Medical Cannabis and Pain Treatment: What Real World Evidence Tells UsFor youPanel discussion
Full London programme

Medical students

Come and change the future of medical cannabis

The clinicians who will define cannabinoid medicine are in medical school now. We’re offering free places for medical students at both symposia — the full day, every session, the same room as the prescribers and researchers shaping the field.

  • A free place at Frankfurt or London — or both
  • Full access to every session and the networking breaks
  • Verified student status is all we ask

How it works

  1. Apply with your university and course details
  2. We verify your student status
  3. Your free booking link arrives by email

Free places for medical students

Free places are for current medical students and are allocated by application. Apply below — once we’ve verified your student status we’ll email you a booking link.

Limited places — apply early.

Book your place

Two cities, one programme philosophy. Choose your symposium — checkout is handled securely by Eventbrite.

Symposium

Frankfurt

4 November 2026 · 09:00 – 16:30

Mainhaus, Germany

Included: 12 months' free MCCS membership — worth up to £120

Secure your place — checkout is handled securely via Eventbrite.

Book tickets

Included: 12 months' free MCCS membership — worth up to £120

Enter your email to continue to checkout for Cannabis Health Symposium: Frankfurt.

Symposium

London

26 November 2026 · 08:30 – 17:00

Conway Hall, United Kingdom

Included: 12 months' free MCCS membership — worth up to £120

Secure your place — checkout is handled securely via Eventbrite.

Book tickets

Included: 12 months' free MCCS membership — worth up to £120

Enter your email to continue to checkout for Cannabis Health Symposium: London.

Questions clinicians ask us

Who is the symposium for?

Doctors, pharmacists, nurses, allied health professionals and researchers working in or around cannabis-based medicines — alongside industry and patient advocates. The programme is written for a clinical audience.

What language are the events in?

Both symposia run in English, including Frankfurt.

Is CPD available?

London: CPD accreditation pending. Frankfurt is not CPD-accredited.

Are there concession tickets for healthcare professionals?

Applications for HCP concession tickets closed on 2 October 2026. Every ticket bought before the end of 2026 still includes 12 months’ free membership of the Medical Cannabis Clinicians Society (MCCS).

How do free medical-student places work?

Apply using the form on this page with your university and course details. We verify your status and email a booking link. Places are limited and allocated in order of application.

How do I claim the MCCS membership?

The redemption code arrives with your Eventbrite order confirmation — it is never published on the site. Membership covers all MCCS tiers for 12 months.